Article
Single application of 2 percent solution clears infection as well as three-day regimen; nonetheless, hyper-, hypopigmentary changes may last for months
Dupilumab Reduces Levels of Immunoglobulin E in Pediatric Patients with Moderate-to-Severe AD
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Understanding and Treating Pediatric AD Inside and Out
The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
Reviewing Complex Cases: Topicals for Pediatric AD
Study Finds Propranolol Initiation for Infantile Hemangiomas Safe with Less Monitoring